{"disease":{"id":"t2d","name":"t2d"},"drugs":{"marketed":[{"drug_id":"canagliflozin","indication_name":"Chronic kidney disease (CKD) associated with type 2 diabetes (T2D)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Invokana","generic_name":"CANAGLIFLOZIN","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Sodium/glucose cotransporter 2","drug_class":"Sodium-Glucose Cotransporter 2 Inhibitor","quality_score":71,"revenue":"800","mechanism":"Invokana works by blocking the SGLT2 protein in the kidneys to reduce glucose reabsorption."},{"drug_id":"finerenone","indication_name":"Chronic kidney disease (CKD) associated with type 2 diabetes (T2D)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kerendia","generic_name":"FINERENONE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]","quality_score":59,"revenue":"600","mechanism":"Kerendia works by blocking the mineralocorticoid receptor, a protein that regulates sodium and potassium levels in the body."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07198191","title":"SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT06769646","title":"SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data","phase":"","overall_status":"COMPLETED","enrollment_count":110074,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06913881","title":"Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":92100,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05628090","title":"A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India","phase":"","overall_status":"COMPLETED","enrollment_count":47885,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT07104422","title":"An Epidemiological and Long-Term Endpoint Registry Study on Disease-Syndrome Correlation Patterns in Comorbid Population With Diabetes and Ischemic Cardio-Cerebrovascular Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Guangzhou University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT06959030","title":"An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Second Affiliated Hospital of Guangxi Medical University","has_results":false},{"nct_id":"NCT07421921","title":"Detecting Type 2 Diabetes From Voice","phase":"","overall_status":"COMPLETED","enrollment_count":7319,"lead_sponsor_name":"Thymia Limited","has_results":false},{"nct_id":"NCT07106879","title":"Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Clindove Research LLC","has_results":false},{"nct_id":"NCT00829660","title":"Acarbose Cardiovascular Evaluation Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":6526,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT06293417","title":"To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM","phase":"NA","overall_status":"RECRUITING","enrollment_count":3958,"lead_sponsor_name":"Korea University Anam Hospital","has_results":false},{"nct_id":"NCT06821399","title":"Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus","phase":"","overall_status":"RECRUITING","enrollment_count":2920,"lead_sponsor_name":"Yufan Wang","has_results":false},{"nct_id":"NCT06984510","title":"Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population","phase":"","overall_status":"RECRUITING","enrollment_count":2720,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT06740708","title":"Scaling Up Community-based Noncommunicable Disease Research Into Practice in Pokhara Metropolitan City of Nepal","phase":"NA","overall_status":"RECRUITING","enrollment_count":2070,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT06694012","title":"Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT07183137","title":"Metabolic Surgery for Metabolic Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":1581,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT07288749","title":"Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1484,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07314749","title":"2025 Hypoglycemia Early-Warning and Physician-Nurse Collaborative Management Trial in Type 2 Diabetes","phase":"NA","overall_status":"COMPLETED","enrollment_count":1255,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT07116928","title":"Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":1244,"lead_sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT01131182","title":"Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1147,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06858878","title":"Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1105,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT06778967","title":"A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Gan & Lee Pharmaceuticals.","has_results":false},{"nct_id":"NCT07437157","title":"The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06976541","title":"Utilization Study and Evaluation of Educational Intervention on HbA1c Testing","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":968,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT05662332","title":"A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":795,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT06906627","title":"Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)","phase":"NA","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06094491","title":"Virtual Diabetes Group Visits Across Health Systems","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":720,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT06833541","title":"Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease","phase":"","overall_status":"RECRUITING","enrollment_count":720,"lead_sponsor_name":"The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT06671587","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":678,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06327815","title":"Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":633,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05680129","title":"A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"Hangzhou Sciwind Biosciences Co., Ltd.","has_results":false},{"nct_id":"NCT04504396","title":"Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":620,"lead_sponsor_name":"PegBio Co., Ltd.","has_results":false},{"nct_id":"NCT02643797","title":"Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":602,"lead_sponsor_name":"Scripps Whittier Diabetes Institute","has_results":false},{"nct_id":"NCT07139548","title":"A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Guangdong Raynovent Biotech Co., Ltd","has_results":false},{"nct_id":"NCT07387393","title":"To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Hawaii","has_results":false},{"nct_id":"NCT07097415","title":"The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT04809220","title":"A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":591,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT03658031","title":"Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":576,"lead_sponsor_name":"Hamad Medical Corporation","has_results":false},{"nct_id":"NCT03437109","title":"Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus","phase":"","overall_status":"COMPLETED","enrollment_count":554,"lead_sponsor_name":"Besins Healthcare","has_results":false},{"nct_id":"NCT06716216","title":"A Study of BGM0504 in Participants with Type 2 Diabetes","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":537,"lead_sponsor_name":"BrightGene Bio-Medical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT06733805","title":"Impact Evaluation of the Therapeutic Initiative's Type 2 Diabetes in Older Adults Portrait and Therapeutics Letter","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":515,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06592950","title":"Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting Insulin","phase":"","overall_status":"COMPLETED","enrollment_count":513,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07241325","title":"Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Sectional Study","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07156370","title":"Salivary Cortisol and Hypercortisolism in Type 2 Diabetes","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Shanghai 6th People's Hospital","has_results":false},{"nct_id":"NCT07046273","title":"Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":496,"lead_sponsor_name":"Shandong New Time Pharmaceutical Co., LTD","has_results":false},{"nct_id":"NCT06686134","title":"Comprehensive Clinical Evaluation Study of GLP-1RA","phase":"","overall_status":"RECRUITING","enrollment_count":492,"lead_sponsor_name":"LI YAN","has_results":false},{"nct_id":"NCT07064486","title":"A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":477,"lead_sponsor_name":"BrightGene Bio-Medical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT06542874","title":"A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06975501","title":"Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":444,"lead_sponsor_name":"Duke Kunshan University","has_results":false},{"nct_id":"NCT07244003","title":"Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":430,"lead_sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06906640","title":"Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)","phase":"NA","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"Duke University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}